BioCryst Pharmaceuticals
- Market cap
- 2.15B
- P/E (TTM)i
- -6.00
- P/Bi
- -4.72
- EPSi
- 1.21
- Div yieldi
- 0.00%
- 52W posi
- 46%
Anonymous reader poll. Unscientific, not investment advice.
BioCryst Pharmaceuticals shares were changing hands at 8.40, up 5.66% on the day. The company carries a market value of roughly 2.15B, the #2766 most valuable US-listed company we track. Across 7 analysts the consensus rating is Buy, with an average price target of 19.57 (+133%). Over the past year the stock has ranged from 6.00 to 11.22; it now sits 46% up that band.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 2 weeks.
- Its last 4 Sell calls were followed by roughly flat moves (-0%) three months out.
- Recent price momentum is -1.4% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has fallen to 13.6% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 7.95
- Open
- 7.91
- Day range
- 7.86 - 8.43
- Avg price
- 8.32
- Volume
- 5.12M
- Turnover
- 42.61M
- Turnover ratei
- 2.30%
- Volume ratioi
- 0.73
- Amplitudei
- 7.11%
- 52-week rangei
- 6.00 - 11.22
Valuation
- P/Ei
- 6.94
- P/E (TTM)i
- -6.00
- P/Bi
- -4.72
- EPSi
- 1.21
- Book value / shi
- -1.78
- Net profit
- 309.20M
- Net assets
- -454.34M
Share structure
- Market cap
- 2.15B
- Float capi
- 1.87B
- Shares out
- 255.54M
- Float sharesi
- 222.32M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
25.1% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-39.05M net over the window
Short interest
- Shares short
- 34.87M
- % of floati
- 13.65%
- Days to coveri
- 7.29
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of BioCryst Pharmaceuticals (BCRX)?
BioCryst Pharmaceuticals last traded at 8.40. The quote on this page refreshes every few seconds while US markets are open.
What is BioCryst Pharmaceuticals's market cap?
About 2.15B.
What is the P/E ratio of BioCryst Pharmaceuticals?
The trailing twelve-month P/E is -6.00. The Valuation tab shows it against the stock's own five-year range.
Does BioCryst Pharmaceuticals pay a dividend?
BioCryst Pharmaceuticals does not currently pay a regular dividend.
Is BioCryst Pharmaceuticals a buy according to analysts?
The consensus of 7 analysts is a Buy rating, with an average 12-month price target of 19.57, which implies 133.0% upside from the current price. This is not investment advice.
What is BioCryst Pharmaceuticals's StockVane Quant Rating?
The StockVane Momentum strategy currently rates BioCryst Pharmaceuticals a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-10-08 05:51:13 · For reference only, not investment advice and not tailored to your situation.